Inspire Medical Investors Get Jan. 5 Deadline Reminder in Securities Suit Over Inspire V Rollout

Law firms seek a lead plaintiff as investors pursue claims tied to alleged misstatements about the Inspire V launch.

Overview

The putative class action is captioned City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., No. 25-cv-04247, in the U.S. District Court for the District of Minnesota.
The alleged class period runs from August 6, 2024 through August 4, 2025 for purchasers of Inspire Medical Systems common stock.
Filings assert the company overstated demand and launch readiness for Inspire V, citing incomplete clinician training, onboarding gaps, and delays in insurer claims software updates.
On August 4, 2025, the company disclosed an elongated rollout, cut 2025 EPS guidance by more than 80%, and the stock fell about 32% following revelations of excess channel inventory and billing readiness issues.
Rosen Law Firm, The Schall Law Firm, Johnson Fistel, and Glancy Prongay & Murray are soliciting investors, and no class has been certified so investors are unrepresented unless they retain counsel.